GLB-002

N/A

Report date: 2026/04/29 10:58:29
NMEFirst In Class

Base Information

Drug NameGLB-002
Drug Alias NameGLB-002
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionDNA-binding protein Ikaros degradersZinc finger protein Aiolos degraders
TargetsDNA-binding protein IkarosZinc finger protein Aiolos
Therapy Area/IndicationsHematologic NeoplasmsMultiple MyelomaLymphoma, Follicular +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGluBio Therapeutics Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHangzhou GluBio Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic NeoplasmsMultiple MyelomaLymphoma, Follicular +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A